Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD Harumi Kato Kazuhito Yamamoto Takeshi Kodaira Yusuke Higuchi Hideyuki Yamamoto Toko Saito Hirofumi Taji Yasushi Yatabe Shigeo Nakamura Tomohiro Kinoshita 10.6084/m9.figshare.5280586.v1 https://tandf.figshare.com/articles/dataset/Immunophenotypic_analysis_of_adult_patients_with_T-cell_lymphoblastic_lymphoma_treated_with_hyper-CVAD/5280586 <p><b>Objectives:</b> Immunophenotype is an important prognostic factor for childhood and adult T-cell acute lymphoblastic leukemia. However, immunophenotypic data from adult patients with T-cell lymphoblastic lymphoma (T-LBL) are scarcely available.</p> <p><b>Methods:</b> Subjects were unselected adult patients with T-LBL who were treated with intensive chemotherapy. Immunophenotyping of tumor cells was performed according to standard techniques.</p> <p><b>Results:</b> A total of eight patients with a median age of 31 years were analyzed who received hyper-CVAD treatment for LBL. Immunophenotypic analysis showed that the most common tumor type was cortical T-cell type [early T (<i>n</i> = 2), cortical T (<i>n</i> = 4), and medullary T (<i>n</i> = 2)]. Two patients diagnosed with early T-cell type had early disease progression.</p> <p><b>Conclusions:</b> Assessment of T-cell differentiation stages in malignant T lymphoblasts would be important in choosing treatment strategies for adult patients with T-LBL.</p> 2017-08-05 05:33:59 Lymphoblastic lymphoma T-cell immunophenotyping hyper-CVAD regimen flow cytometry